至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Substrate specificity of the galactokinase from the human gut symbiont Akkermansia muciniphila ATCC BAA-835

Enzyme and Microbial Technology. 2020-04; 
Xunlian Zhang, Weihao Sheng, Kun Li, Yongheng Rong, Qizheng Wu, Qingyun Meng, Yun Kong, Min Chen
Products/Services Used Details Operation
Gene Synthesis The gene encoding GalKAmu (Amuc_0969) in the A. muciniphila ATCC BAA-835 genome (GenBank accession No.CP001071.1) was synthesized and cloned into pET-45b (with an N-terminal His₆-tag) by GenScript Corporation (Nanjing, China). Get A Quote

摘要

Galactokinases, which catalyze the phosphorylation of galactose and possibly other monosaccharides, can provide an activated sugar donor to synthesize sugar-containing molecules. In this study, a novel galactokinase from human gut symbiont Akkermansia muciniphila ATCC BAA-835 (GalKAmu) was expressed and characterized. GalKAmu displayed broad substrate tolerance, with catalytic activity towards Gal (100%), GalN (100%), GalA (20.2%), Glc (52.5%), GlcNAc (15.5%), Xyl (<5%), ManNAc (58%), ManF (37.4%) and L-Glc (80%). Most interestingly, this was the first GalK isoform which can tolerate ManNAc. Thus, our characterization of GalKAmu broadens the substrate selection of galactokinases.

关键词

GalactokinaseEnzymatic synthesisSugar-1-phosphatesSugar nucleotidesSubstrate specificityAkkermansia muciniphila ATCC BAA-835